"TPN-101 is the first LINE-1 nucleoside reverse transcriptase inhibitor to show promise for the treatment of a range of neurodegenerative disorders for which few, if any, effective treatments are ...
24-Week data show TPN-101 is the first treatment for PSP to reduce NfL levels, a key biomarker of neurodegeneration in tauopathies such as PSP and Alzheimer's disease TPN-101 also showed a reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results